Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 1, 1982
Analgesia, new research approaches
M Morre, R Boigegrain, R Roncucci
Bioorganic & Medicinal Chemistry Letters
|
January 1, 1999
X-ray structural characterization of SR 142948, a novel potent synthetic neurotensin receptor antagonist
L Quéré, G Longfils, R Boigegrain, et al.
Life Sciences
|
January 1, 1983
Kappa binding sites in guinea-pig brain membranes: evidence for a dynorphin-resistant subtype
M Morre, A Bachy, B Gout, et al.
Pharmacological Research Communications
|
February 1, 1988
Inhibition of rat colon motility by stimulation of atypical beta-adrenoceptors with new gut-specific agents
T Croci, R Cecchi, A Tarantino, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 1, 1993
Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor
D Gully, M Canton, R Boigegrain, et al.
European Journal of Pharmacology
|
April 1, 1994
Neurotensin receptor interaction with dopaminergic systems in the guinea-pig brain shown by neurotensin receptor antagonists
M Azzi, D Gully, M Heaulme, et al.
Psychopharmacology
|
January 1, 1993
SR 46559A: a novel and potent muscarinic compound with no cholinergic syndrome
J P Kan, R Steinberg, F Oury-Donat, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 1, 1997
Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist
D Gully, B Labeeuw, R Boigegrain, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 24, 1999
SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. II. In vivo pharmacological characterization
E Bignon, R Alonso, M Arnone, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 24, 1999
SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. I. In vitro studies
E Bignon, A Bachy, R Boigegrain, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 1, 1982
Analgesia, new research approaches
M Morre, R Boigegrain, R Roncucci
Bioorganic & Medicinal Chemistry Letters
|
January 1, 1999
X-ray structural characterization of SR 142948, a novel potent synthetic neurotensin receptor antagonist
L Quéré, G Longfils, R Boigegrain, et al.
Life Sciences
|
January 1, 1983
Kappa binding sites in guinea-pig brain membranes: evidence for a dynorphin-resistant subtype
M Morre, A Bachy, B Gout, et al.
Pharmacological Research Communications
|
February 1, 1988
Inhibition of rat colon motility by stimulation of atypical beta-adrenoceptors with new gut-specific agents
T Croci, R Cecchi, A Tarantino, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 1, 1993
Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor
D Gully, M Canton, R Boigegrain, et al.
European Journal of Pharmacology
|
April 1, 1994
Neurotensin receptor interaction with dopaminergic systems in the guinea-pig brain shown by neurotensin receptor antagonists
M Azzi, D Gully, M Heaulme, et al.
Psychopharmacology
|
January 1, 1993
SR 46559A: a novel and potent muscarinic compound with no cholinergic syndrome
J P Kan, R Steinberg, F Oury-Donat, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 1, 1997
Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist
D Gully, B Labeeuw, R Boigegrain, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 24, 1999
SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. II. In vivo pharmacological characterization
E Bignon, R Alonso, M Arnone, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 24, 1999
SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. I. In vitro studies
E Bignon, A Bachy, R Boigegrain, et al.
Page
of 1